培元汤配合穴位注射减轻结肠癌化疗副反应的临床观察  被引量:3

Clinical Observation on Peiyun Decoction Combine with Acupoint Injection for Relieving the Adverse Reaction of Patients with Colon Cancer after Chemotherapy

在线阅读下载全文

作  者:张宝昕 段圣刚[1] 刘博[1] 白振霞[1] 张玉[1] 

机构地区:[1]河北省沧州中西医结合医院肿瘤外科,河北沧州061001

出  处:《中国中医药现代远程教育》2017年第13期87-88,共2页Chinese Medicine Modern Distance Education of China

摘  要:目的观察自拟培元汤配合穴位注射在减轻结肠癌患者化疗后(奥沙利铂+卡培他滨)副反应的临床效果。方法将符合纳入标准的60例结肠癌患者随机分为观察组与对照组,各30例。对照组给予XELOX方案化疗,观察组在实施XELO X化疗方案的同时服用自拟培元汤并配合足三里穴位注射治疗。实施3周期化疗后,参照WHO抗癌药物毒副作用评定标准作毒副作用比较。结果 2组患者毒副反应主要表现为血液系统的白细胞减少、血红蛋白及血小板减少,消化系统的恶心、呕吐;2组毒副反应比较差异具有统计学意义(P<0.05);实验组治疗前白细胞与实验组治疗后白细胞两者比较,差异有统计学意义(P<0.05)。结论自拟培元汤配合穴位注射可有效减轻结肠癌患者化疗后副反应。Objective To observe the clinical effect of Peiyuan decoction combined with acupoint injection for relieving the adverse reaction of patients with colon cancer after chemotherapy. Methods 60 cases of patients with colon cancer met the inclusion criteria were randomly divided into two groups, with 30 cases in each group. The control group was given XELOX chemotherapy, and the observation group was given XELOX chemotherapy and Peiyuan Decoction combined with acupoint injection foundation treatment. After the implementation of the 3 cycles of chemotherapy, according to standard anticancer drug toxicity WHO, the adverse reaction was evaluated. Results In the two groups, adverse reaction was mainly hematological leueopenia, hemoglobin and platelet decrease, the digestive system of nausea and vomiting; and there was significant difference (P〈 0.05) . Before and after treatment, white blood cells of the observation group were compared, and there were significant differences (P〈 0.05) . Conclusion Peiyuan decoction and acupoint injection can effectively reduce the side effects of chemotherapy in patients with colon cancer.

关 键 词:结肠癌 XELOX方案 培元汤 穴位注射 肿瘤 化疗 

分 类 号:R735.35[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象